Search
Now showing items 41-50 of 1797
High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma
Greiner, Jochen et al. (2010)
Wissenschaftlicher Artikel
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
Grenier, J et al. (2002)
Wissenschaftlicher Artikel
Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia
Greiner, Jochen et al. (2012)
Wissenschaftlicher Artikel
Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
Greiner, Jochen et al. (2006)
Wissenschaftlicher Artikel
Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1(mut))
Greiner, Jochen et al. (2013)
Wissenschaftlicher Artikel
Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
Greiner, Jochen et al. (2008)
Wissenschaftlicher Artikel
Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group
Kovacs, Gabor et al. (2016)
Wissenschaftlicher Artikel
Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias
Kossak-Roth, Ute et al. (2016)
Wissenschaftlicher Artikel
IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)
Kroenke, J. et al. (2017)
Wissenschaftlicher Artikel
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
Koreth, John et al. (2009)
Wissenschaftlicher Artikel